de Yébenes JG - Search Results

1

[Klüver-Bucy syndrome as the initial symptom of adult-type ceroid lipofuscinosis (Kufs' disease)].

Alonso-Navarro H, Jiménez-Jiménez FJ, Puertas-Muñoz I, Rábano J, de Yébenes JG, Sarasa-Corral JL. Alonso-Navarro H, et al. Among authors: de yebenes jg. Rev Neurol. 2005 Jan 16-31;40(2):93-8. Rev Neurol. 2005. PMID: 15712163 Free article. Spanish.

2

[Craniocervical dystonia and facial hemispasm: clinical and pharmacological characteristics of 52 patients].

Astarloa R, Morales B, Peñafiel N, Rábano J, de Yébenes JG. Astarloa R, et al. Among authors: de yebenes jg. Rev Clin Esp. 1991 Nov;189(7):320-4. Rev Clin Esp. 1991. PMID: 1767088 Spanish.

3

Molecular findings in familial Parkinson disease in Spain.

Hoenicka J, Vidal L, Morales B, Ampuero I, Jiménez-Jiménez FJ, Berciano J, del Ser T, Jiménez A, Ruíz PG, de Yébenes JG. Hoenicka J, et al. Among authors: de yebenes jg. Arch Neurol. 2002 Jun;59(6):966-70. doi: 10.1001/archneur.59.6.966. Arch Neurol. 2002. PMID: 12056932

4

Hereditary branchial myoclonus with spastic paraparesis and cerebellar ataxia: a new autosomal dominant disorder.

de Yebenes JG, Vazquez A, Rabano J, de Seijas EV, Urra DG, Obregon MC, Barquero MS, Arribas MA, Moreno JL, Alenda JR. de Yebenes JG, et al. Among authors: de seijas ev. Neurology. 1988 Apr;38(4):569-72. doi: 10.1212/wnl.38.4.569. Neurology. 1988. PMID: 3352913

5

[A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].

de Yébenes JG, García-Ruiz PJ, Sánchez-Pernaute R. de Yébenes JG, et al. Rev Neurol. 1997 Sep;25(145):1343-5. Rev Neurol. 1997. PMID: 9377286 Spanish.

6

[Glia conditioned medium offers protection against the toxicity induced by 6-OH-dopamine in vivo].

Rojo A, Mena-Gómez MA, Blázquez A, Casarejos MJ, Fontán-Barreiro A, de Yébenes JG. Rojo A, et al. Among authors: de yebenes jg. Rev Neurol. 2002 Jun 16-30;34(12):1112-8. Rev Neurol. 2002. PMID: 12134273 Free article. Spanish.

7

Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson disease.

Astarloa R, Mena MA, Sánchez V, de la Vega L, de Yébenes JG. Astarloa R, et al. Among authors: de la vega l, de yebenes jg. Clin Neuropharmacol. 1992 Oct;15(5):375-80. doi: 10.1097/00002826-199210000-00004. Clin Neuropharmacol. 1992. PMID: 1330307

8

Cinnarizine-induced parkinsonism in primates.

García Ruiz PJ, Mena MA, Peñafiel N, De Yébenes JG. García Ruiz PJ, et al. Among authors: de yebenes jg. Clin Neuropharmacol. 1992 Apr;15(2):152-4. doi: 10.1097/00002826-199204000-00010. Clin Neuropharmacol. 1992. PMID: 1375537

9

Huntington's disease: a multidisciplinary study.

Ruiz PJ, Del Barrio A, Barroso T, Tortosa EG, Benitez J, Astarloa R, De Yébenes JG. Ruiz PJ, et al. Among authors: de yebenes jg. Eur J Neurol. 1995 Jul;2(3):185-91. doi: 10.1111/j.1468-1331.1995.tb00115.x. Eur J Neurol. 1995. PMID: 24283636

10

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.

Zarranz JJ, Alegre J, Gómez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atarés B, Llorens V, Gomez Tortosa E, del Ser T, Muñoz DG, de Yebenes JG. Zarranz JJ, et al. Among authors: de yebenes jg. Ann Neurol. 2004 Feb;55(2):164-73. doi: 10.1002/ana.10795. Ann Neurol. 2004. PMID: 14755719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page